HARMONY celebrated its 3rd General Assembly to discuss about the progress of the project. One of the main messages conveyed was the importance of the involvement of European data custodians from the hematological community as Associated Members of HARMONY (currently 27 organisations) and the announcement of the first data set harmonized within the data platform. In this regard, it was emphasized the key role of an “honest broker” to ensure the data double anonymization. This role is being successfully carried out by Synapse for the pilot research projects within HARMONY. Data harmonization will contribute to the extraction of relevant insights and specific outcomes that are relevant to improve treatments of patients with hematological diseases across Europe.
HARMONY, launched on the 1st of January 2017, counts with the participation of more than 150 experts and has been sponsored by the European Union’s Horizon 2020 research and innovation programme and the European pharmaceutical industry (via EFPIA) under the auspices of the Innovative Medicines Initiative 2 Joint Undertaking.
More about HARMONY at https://www.harmony-alliance.eu/